CERo Therapeutics Holdings Inc’s recent filing unveils that its 10% Owner YK Bioventures Opportunities G unloaded Company’s shares for reported $0.18 million on Dec 13 ’24. In the deal valued at $0.06 per share,2,998,908 shares were sold. As a result of this transaction, YK Bioventures Opportunities G now holds 13,005,169 shares worth roughly $0.65 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, YK Bioventures Opportunities G sold 1,614,541 shares, generating $113,018 in total proceeds. Upon selling the shares at $0.07, the 10% Owner now owns 16,004,077 shares.
Before that, YK Bioventures Opportunities G sold 1,343,801 shares. CERo Therapeutics Holdings Inc shares valued at $107,504 were divested by the 10% Owner at a price of $0.08 per share. As a result of the transaction, YK Bioventures Opportunities G now holds 17,618,618 shares, worth roughly $0.88 million.
Price Performance Review of CERO
On Monday, CERo Therapeutics Holdings Inc [NASDAQ:CERO] saw its stock fall -9.98% to $0.05. Over the last five days, the stock has lost -0.98%. CERo Therapeutics Holdings Inc shares have fallen nearly -99.54% since the year began. Nevertheless, the stocks have fallen -99.53% over the past one year. While a 52-week high of $12.80 was reached on 02/06/24, a 52-week low of $0.05 was recorded on 12/17/24. SMA at 50 days reached $0.1258, while 200 days put it at $0.6076.
Levels Of Support And Resistance For CERO Stock
The 24-hour chart illustrates a support level at 0.0456, which if violated will result in even more drops to 0.0408. On the upside, there is a resistance level at 0.0577. A further resistance level may holdings at 0.0650. The Relative Strength Index (RSI) on the 14-day chart is 35.42, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0331, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 97.61%. Stochastics %K at 4.29% indicates the stock is a buying.
How much short interest is there in CERo Therapeutics Holdings Inc?
A steep rise in short interest was recorded in CERo Therapeutics Holdings Inc stocks on 2024-10-31, dropping by -0.72 million shares to a total of 1.6 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 2.32 million shares. There was a decline of -44.92%, which implies that there is a negative sentiment for the stock.
